INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer

NCT00008255 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: INS316
OTHER: sputum cytology

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]